Answer
The mean plasma elimination half-life of palbociclib in patients with advanced breast cancer is 28.8 hours.
Sources for this answer
- IBRANCE 75 mg film-coated tabletsPfizer Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 10Document updated
Sources checked